Conquering Diseases

Addition Of An Investigational Drug To The Usual Treatment For Limited Stage Small Cell Lung Cancer (Ls-Sclc)

Description

Men and women with limited-stage small cell lung cancer, which has not spread outside of their chest area sought for a study comparing how cancer responds when adding an investigational drug to the usual treatment for small cell lung cancer

Overview

We are studying if adding the Investigational drug to the usual treatment of chemoradiotherapy can help lower the chance of small cell lung cancer growing or spreading.

What we're hoping for

We hope the investigational drug will be as good or better than the usual treatment in reducing and controlling small cell lung cancer

Additional Information

ClinicalTrials.gov Identifier: NCT03811002

 Principal Investigator

William  Walsh, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989